PDF(Pubmed)
Abstract：
Mexico\'s national human papillomavirus (HPV) vaccination program was established in 2008, providing free access to HPV vaccines and quickly becoming an immense success story, achieving significant coverage among young Mexican females. However, despite these efforts and notable achievements, cervical cancer caused mainly by HPV remains a challenging issue among Mexican women aged 15 years or older. A critical obstacle faced by women in the country is a lack of early detection and screening resources, coupled with delays in diagnosis and treatment, exacerbated by the poor distribution of already insufficient healthcare resources. This situation creates adverse conditions for the female demographic in the country. Our editorial aims to draw attention to the urgent need to improve access to adequate prevention, screening, and treatment for cervical cancer patients in Mexico, advocating for a collective effort between the Mexican government, public health professionals, and civil society.
摘要：
墨西哥的国家人乳头瘤病毒（HPV）疫苗接种计划成立于2008年，免费提供HPV疫苗，并迅速成为一个巨大的成功故事，在墨西哥年轻女性中实现显著覆盖。然而,尽管做出了这些努力和显著成就，在15岁或以上的墨西哥女性中，主要由HPV引起的宫颈癌仍然是一个具有挑战性的问题。该国妇女面临的一个关键障碍是缺乏早期检测和筛查资源，加上诊断和治疗的延误，由于本已不足的医疗资源分配不畅而加剧。这种情况为该国的女性人口创造了不利的条件。我们的社论旨在提请注意迫切需要改善获得适当预防的机会，筛选,以及在墨西哥对宫颈癌患者的治疗，倡导墨西哥政府之间的集体努力，公共卫生专业人员,和民间社会。
